Investors who own more than 5% of a class must file a Schedule 13D or 13G. Every filing since 12/18/2024, newest first.

Issuer % of Class Filed
Silence Therapeutics plc 13G/A Amendment 6
G8128Y157
4.2% 2/9/2026
Event 12/31/2025
Silence Therapeutics plc 13G/A Amendment 5
G8128Y157
7.6% 2/11/2025
Event 12/31/2024